Coherus BioSciences Inc (NAS:CHRS)
$ 1.88 -0.03 (-1.57%) Market Cap: 215.68 Mil Enterprise Value: 440.51 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Coherus BioSciences Inc - Coherus-Junshi Collaboration Announcement Webcast and Conference Call Transcript

Feb 01, 2021 / 01:00PM GMT
Release Date Price: $17.6 (-6.38%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Coherus BioSciences, Inc. conference call. (Operator Instructions) I would now like to hand the conference over to your first speaker for today, Mr. McDavid Stilwell. Please go ahead.

McDavid Stilwell
Coherus BioSciences, Inc. - EVP of Corporate Development, IR & Financial Strategy

Thank you, operator. Good morning, everyone, and thank you for joining us. We issued a press release earlier announcing our collaboration with Junshi BioSciences. This release can be found on the Coherus BioSciences website.

Today's call includes forward-looking statements regarding Coherus' current expectations. These statements include, but are not limited to, statements relating to our collaboration with Junshi BioSciences, the stock purchase agreement between Coherus and Junshi BioSciences, our co-development of toripalimab monotherapy and combinations, our ability to successfully register toripalimab in the United States and Canada, our ability to successfully commercialize toripalimab and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot